BioCentury
ARTICLE | Financial News

Microbiome company Vedanta raises $27M series C round

January 4, 2019 4:01 AM UTC

With $27 million in new series C funding, microbiome company Vedanta Biosciences Inc. (Cambridge, Mass.) intends to fund a handful of clinical trials to treat food allergies, cancer and bacterial infections.

Investors included the Bill & Melinda Gates Foundation, Bristol-Myers Squibb Co. (NYSE:BMY), Rock Springs Capital, Invesco Asset Management, Seventure Partners and PureTech Health plc (LSE:PRTC)...